The neurologic pain signature responds to nonsteroidal anti-inflammatory treatment vs placebo in knee osteoarthritis

INTRODUCTION: Many drug trials for chronic pain fail because of high placebo response rates in primary endpoints. Neurophysiological measures can help identify pain-linked pathophysiology and treatment mechanisms. They can also help guide early stop/go decisions, particularly if they respond to veru...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Solà, Marina, Pujol, Jesus, Monfort, Jordi, Deus, Joan, Blanco-Hinojo, Laura, Harrison, Ben J., Wager, Tor D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Musculoskeletal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853614/
https://www.ncbi.nlm.nih.gov/pubmed/35187380
http://dx.doi.org/10.1097/PR9.0000000000000986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853614/
https://www.ncbi.nlm.nih.gov/pubmed/35187380
http://dx.doi.org/10.1097/PR9.0000000000000986

Ejemplares similares